PT  - JOURNAL ARTICLE
AU  - Jean, Charline
AU  - Paillaud, Elena
AU  - Boudou-Rouquette, Pascaline
AU  - Martinez-Tapia, Claudia
AU  - Pamoukdjian, Frédéric
AU  - Hagège, Meoïn
AU  - Bréant, Stéphane
AU  - Hassen-Khodja, Claire
AU  - Natella, Pierre-André
AU  - Cudennec, Tristan
AU  - Laurent, Marie
AU  - Caillet, Philippe
AU  - Audureau, Etienne
AU  - Canouï-Poitrine, Florence
TI  - Hospital Care Trajectories of Older Adults with Cancer and the Associated Clinical Profiles: linking a French Prospective Cohort Study and a Clinical Data Warehouse
AID  - 10.1101/2024.02.02.24302125
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.02.02.24302125
4099  - http://medrxiv.org/content/early/2024/02/03/2024.02.02.24302125.short
4100  - http://medrxiv.org/content/early/2024/02/03/2024.02.02.24302125.full
AB  - Background The longitudinal hospital care experiences of older adults with cancer, from the treatment decision-making process until their end of life, remain unexplored. We examined the hospital care trajectories of these patients and identified associated clinical determinants.Methods We linked the ELCAPA multicenter cohort study (patients aged ≥70 with a solid tumor and having been referred for a geriatric assessment between 2012 and 2019) and the Greater Paris University Hospitals’ clinical data warehouse. Individual care trajectories, defined as series of consultations, hospital admissions (in day, acute or rehabilitation units) and emergency room visits, were clustered using multichannel sequence analysis. Cluster membership determinants were identified among socio-demographic, oncological and geriatric parameters by logistic regression analysis.Results 707 patients (median age: 82; metastatic cancer: 45.2%; 10,998 care episodes) were included. Four trajectory clusters were identified: cluster A (n=149, 21.1%) with in-hospital surgical trajectories, cluster B (n=198, 28.0%) with outpatient care trajectories with chemotherapy and/or radiotherapy, cluster C (n=302, 42.7%) without any hospital cancer treatments, and cluster D (n=58, 8.2%) with mostly chemotherapy and high hospital care consumption. Cluster belonging determinants included metastatic status and cancer site (for cluster A), cognition, mobility and mood status (unimpaired parameters for cluster B and impaired for cluster C), and younger age (for cluster D).Conclusion While highlighting varied hospital care experiences among older patients with cancer, we found that age remains an independent determinant of chemotherapy-dominant care trajectories.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe ELCAPA study was funded by the French National Cancer Institute (Institut National du Cancer, INCa), Canceropole Ile-de-France, Gerontopole Ile-de-France (Gerond'If), Curie Institute, none of which had any role in the design and conduct of the study, the collection, management, analysis, and interpretation of the data, the preparation, review and approval of the manuscript or the decision to submit the manuscript for publication. Part of the conducted research was funded by the AP-HP research foundation through the AI-Racles Chair.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The present research was approved by the Greater Paris University Hospitals' Clincal DataWarehouse institutional review board (IRB 00011591, Paris, France; reference: CSE 21-49). The Elderly Cancer Patients (ELCAPA) study has been registered at ClinicalTrials.gov (identifier: NCT02884375). The study protocol was approved by an institutional review board (CPP Ile-de-France I, Paris, France; reference: May 2019-MS121). All patients provided their verbal, informed consent before inclusion.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes